The immunohistochemical expression Ki-67 In Polymorphous Low Grade Adenocarcinoma of the Salivary Glands

Authors

  • Mustafa Mohammed Abdulhussain

DOI:

https://doi.org/10.32828/mdj.v16i1.1028

Keywords:

Ki-67, Polymorphous Low Grade Adenocarcinoma, immunohistochemistry

Abstract

Background: Polymorphous Low Grade Adenocarcinoma is a rare malignant tumor of minor salivary glands. It has an unique histopathological, clinical and behavioural features. Most of its incidence has been presented in the palate. It shows a variety of growth patterns within the same one lesion, including cribriform, tubular, and solid areas that may mimic adenoid cystic carcinoma. The tumor cells histologically are characterized by lacking of nuclear atypical and hyperchromatism with rare mitoses. However, the prognosis of this tumor is good because of its low grade, although it has an unpredictable potential to metastasize.

Objectives: To evaluate the histopathological expression of Ki-67 proliferation antigen in Polymorphous low grade adenocarcinoma and compare the results with the clinicopathological parameters and grading of the tumors.

Materials and Methods: This study includes 20 cases with Polymorphous Low Grade Adenocarcinoma of minor salivary glands diagnosed histopathologically and treated surgically, were investigated for the immunohistochemical expression of Ki-67 antigen. Immunohistochemical staining was performed using a Labeled Strept- Avidin Biotin method (LSAB) and 0.05 (two-sided) was the level of significance.

Results: Twenty cases of Polymorphous Low Grade Adenocarcinoma of salivary glands were histologically diagnosed in this retrospective study to evaluate the expression of Ki-67. The mean age for patients with PLGA was nearly (50.6). (12) (60%) cases were males and (8) (40%) cases were females and also male to female ratio was (1.5:1).

In regarding to site distribution, the most common site was the palate followed by the submandibular gland and floor of the mouth. 

Conclusions: it was observed that there is a higher rate of cellular proliferation in malignant tumors with high grade, indicating their role in the malignancy and aggressive behavior of these tumors.

References

- Regezi JA, Sciubba JJ, Jordan RCK. Oral Pathology: Clinical Pathologic Correlations .5th Edition, Louis, Saunders, 2008; P: 205.

- Kumar M, Stivaros N, Barrett AW, Thomas GJ, Bounds G, Newman L. Polymorphous low-grade adenocarcinoma--a rare and aggressive entity in adolescence. Br J Oral Maxillofac Surg. 2004; 42(3): 195 – 199.

- Wei YC, Huang CC, Chien CY, Hwang JC, Chen WJ. Polymorphous low-grade adenocarcinoma of the nasopharynx: a case report and brief review. J Clin Pathol. 2008; 61(10): 1124 – 1126.

- Moore BA, Burkey BB, Netterville JL, Butcher RB 2nd, Amedee RG (2008). Surgical management of minor salivary gland neoplasms of the palate. Ochsner J, 8(4): 172-180.

- Saghravanian N, Mohtasham N, Jafarzadeh H. Comparison of immunohistochemical markers between adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. J Oral Sci. 2009; 51(4): 509 – 514.

- Cheuk W and Chan JK: Advances in salivary gland pathology. Histopathology 51: 1-20, 2007.

- Habberstad AH, Gulati S, Torp SH. Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisom erase IIα in human anaplastic astrocytomas - an immunohistochemical study. Diagn Pathol 2011; 6: 43-50.

- Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002; 40: 2-11.

- Bullwinkel J, Baron-Lühr B, Lüdemann A, Wohlenberg C, Gerdes J, Scholzen T (2006). Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol, 206, 624-35.

- Scholzen T, Gerdes J (2000). The Ki-67 protein: from the known and the unknown”. J Cell Physiol, 182, 311-22.

- Cheuk W and Chan JKC: Salivary glands tumors. In: Diagnostic Histopathology of Tumors. Fletcher CDM (ed). Livingstone, Churchill, pp239-326, 2007.

- Seethala RR, Johnson JT, Barnes EL, Myers EN (2010). Polymorphous low-grade adenocarcinoma: The University of Pittsburgh experience. Arch Otolaryngol Head Neck Surg, 136(4): 385-392.

- Batsakis JG, Pinkston GR, Luna MA, et al. Adenocarcinomas of the oral cavity: a clinicopathologic study of terminal duct carcinomas. J Laryngo1 Otol. 1983; 97:825-835.

- Clayton JR, Pogrel MA, Regezi JA. Simultaneous multifocal poly¬morphous low-grade adenocarcinoma. Report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80(1):71–7.

- Gnepp RD, Henley DJ, Simpson HWS, Eveson J. Diagnostic Surgi¬cal Pathology of the Head and Neck. 2th edUSA: Elsevier Health Sci¬ences; 2009.

- Quinn CM, Wright NA. The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 1990; 160: 93-102

- Tadbir AA, Pardis S, Ashkavandi ZJ, Najvani AD, Ashraf MJ, Taheri A, et al. Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors. Asian Pac J Cancer Prev 2012; 13: 5155-9.

- Trandafirescu M, Cotuțiu C, Cojocaru E, Foia L. Immunohistochemical Aspects In Pleomorphic Adenoma, Related To Its Histogenesis And Malignization. Romanian J Oral Rehabil 2012; 4: 11-6.

- Curran AE, White DK, Damm DD, Murrah VA. Polymorphous low-grade adenocarcionma versus pleomorphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acid protein.Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:194–199.

- Simpson RH, Pereira EM, Ribeiro AC, Abdulkadir A, Reis-Filho JS. Polymorphous low-grade adenocarcinoma of the salivary glands with transformation to high-grade carcinoma. Histopathology 2002;41: 250–259.

- Nordgard S, Franzén G, Boysen M, Halvor.sen TB (1997). Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB 1 in paraffin sections. Laryngoscope, 107,531-6.

- 22- Spyratos F, Ferrero-Poüs M, Trassard M, et al: Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. Cancer 94: 2151-2159, 2002.

- 23- Staibano S, Mascolo M, Mancini FP, et al: Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of

Downloads

Published

24.01.2024

How to Cite

Mohammed Abdulhussain , M. . (2024). The immunohistochemical expression Ki-67 In Polymorphous Low Grade Adenocarcinoma of the Salivary Glands. Mustansiria Dental Journal, 16(1), 89–95. https://doi.org/10.32828/mdj.v16i1.1028